← FDA DRUG APPROVALS

FDA ANDA · ANDA062008

NEBCIN

Sponsor: LILLY

APPLICATION
ANDA062008
TYPE
ANDA
ORIGINAL APPROVAL
1976-10-01
LATEST ACTION
1992-06-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NEBCINDiscontinued
TOBRAMYCIN SULFATE EQ 40MG BASE/ML · INJECTABLE · INJECTION
NEBCINDiscontinued
TOBRAMYCIN SULFATE EQ 10MG BASE/ML · INJECTABLE · INJECTION

Approval history

1992-06-18Labeling · Supplement 16AP
1990-04-10Labeling · Supplement 11AP
1976-10-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →